SoloVital has recalled approximately 1,331 bottles of Umary Acido Hialuronico (Suplemento Alimenticio) 850 mg caplets. FDA analysis found the product was tainted with undeclared diclofenac and omeprazole, which are not listed on the label. This recall covers all lots currently within their expiration dates. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) and omeprazole is used to treat stomach acid; using these ingredients without medical supervision can lead to serious health complications.
Undeclared diclofenac can increase the risk of heart attack, stroke, and serious gastrointestinal damage, especially when taken with other NSAIDs. Omeprazole can mask symptoms of serious stomach conditions and interact with other medications, potentially leading to unintended side effects or toxicity.
You have 2 options:
1,331 bottles affected.
“Front label on bottle, Umary Acido Hialuronica, Suplemento Alimenticio, 30 Capletas de 850mg”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.